The phrase "attached target" is correct and usable in written English.
It can be used in contexts where you are referring to a target that is physically or metaphorically attached to something else, such as in a project or a document.
Example: "Please review the attached target document for the project specifications."
Alternatives: "linked target" or "connected target".
The surface of porous silicon can also be easily modified with desired functional groups and covalently attached targeting biomolecules [20].
Modification of the nanoparticle surface with covalently attached targeting ligands or by coating with certain surfactants had enabled the adsorption of specific plasma proteins.
Previously, single-molecule strategies related to nanomaterials have included characterizing QDs [ 7– 9] and detecting attached targeting agents [ 10, 11] or determining the stoichiometry of biological complexes such as membrane-bound protein assemblies [ 12– 12].
Moreover, modification of nanoparticle surface with covalently attached targeting ligands or by coating with certain surfactants is essential for receptor mediated uptake or adsorption of specific plasma proteins after injection in human.
Specific targeting can be obtained by attaching targeting molecules to the QD surface.
A common approach is to attach targeting ligands in order to activate receptor-mediated endocytosis.
The outer walls of the nanotubes are functionalized by attaching target-specific molecules (e.g., antibodies) and drugs can be delivered to specific targets [145].
Given that these SGSs are non-toxic up to 10 μg/ml, we feel they can be used as an adequate scaffold to simultaneously attach targeting moieties such as EGFR antibodies (e.g., cetuximab, C225) and chemo-agents such as doxorubicin and gemcitabine in a bid to treat hepatocellular carcinoma legions.
Thus, by attaching targeting molecules or peptides, these lipid nanoparticles could provide high specificity and low off-target accumulation for targeting to tumor receptors accessible through blood, i.e. leaky tumor-associated vasculature.
